Analysed TYRA BIOSCIENCES INC (TYRA:NASDAQ) News Sources
A Look At Tyra Biosciences (TYRA) Valuation After $126 Million Stock Sale And Late Stage Trial Progress
04-04-2026
yahoo.com
This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position
20-03-2026
fool.com
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet.
19-03-2026
fool.com
Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit
18-03-2026
fool.com
Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit
18-03-2026
fool.com
Did Deeper Losses and Dabogratinib Progress Just Shift Tyra Biosciences' (TYRA) Investment Narrative?
04-03-2026
yahoo.com
Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights
02-03-2026
yahoo.com
Tyra Biosciences Narrows Dabogratinib Focus, Teases Mid-Year NMIBC and 2H Achondroplasia Data
02-03-2026
marketbeat.com
Tyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium
23-02-2026
yahoo.com
What is the current price of TYRA BIOSCIENCES INC (TYRA:NASDAQ)?
The current price of TYRA BIOSCIENCES INC (TYRA:NASDAQ) is $35.26.
TYRA BIOSCIENCES INC (TYRA:NASDAQ) absolute price change since previous trading day?
The absolute price change of TYRA BIOSCIENCES INC (TYRA:NASDAQ) since the previous trading day is $-1.43.
TYRA BIOSCIENCES INC (TYRA:NASDAQ) percentage price change since previous trading day?
The percentage price change of TYRA BIOSCIENCES INC (TYRA:NASDAQ) since the previous trading day is -3.8975%.
What is the most recent average sentiment score for TYRA BIOSCIENCES INC (TYRA:NASDAQ)?
The most recent average sentiment score for TYRA BIOSCIENCES INC (TYRA:NASDAQ) is 89 out of 100.
What is the most recent average sentiment for TYRA BIOSCIENCES INC (TYRA:NASDAQ)?
The most recent sentiment for TYRA BIOSCIENCES INC (TYRA:NASDAQ) is .
SEC-8K** Filing Available For TYRA BIOSCIENCES INC (TYRA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.